'I don't feel like a diabetic any more': The impact of stopping insulin in patients with maturity onset diabetes of the young following genetic testing

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 4, Issue 2, 2004, Pages 144-147

  Shepherd, Maggie ^b   Hattersley, Andrew T ^a,b  

^a Department of Molecular Medicine ^*

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

Genetic testing; Hepatocyte nuclear factor 1 (HNF 1 ); Maturity onset diabetes of the young (MODY); Sulphonylurea sensitivity

Indexed keywords

INSULIN; NUCLEAR FACTOR I; NUCLEAR FACTOR I ALPHA; SULFONYLUREA; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; DNA BINDING PROTEIN; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; NUCLEAR PROTEIN; TCF1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADOLESCENT; ADULT; ANXIETY; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; EXCITEMENT; FEAR; GENETIC ANALYSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIFESTYLE; MATURITY ONSET DIABETES MELLITUS; MONOGENIC DISORDER; REVIEW; SELF CONCEPT; TREATMENT WITHDRAWAL; ARTICLE; EMOTION; GENETICS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PSYCHOLOGICAL ASPECT; TIME;

ADOLESCENT; ADULT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIAGNOSTIC ERRORS; DNA-BINDING PROTEINS; EMOTIONS; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIFE STYLE; MIDDLE AGED; NUCLEAR PROTEINS; SELF CONCEPT; TIME FACTORS; TRANSCRIPTION FACTORS; WITHHOLDING TREATMENT;

EID: 4043169983     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.4-2-144     Document Type: Review

References (13)

1. Stride A, Hattersley AT. Different genes, different diabetes: lessons from maturity-onset diabetes of the young. Review. Ann Med 2002;34: 207-16.
2. Hathout EH, Cockburn BN, Mace JW, Sharkney J et al. A case of hepatocyte nuclear factor-1 alpha diabetes/MODY3 masquerading as type 1 diabetes in a Mexican-American adolescent and responsive to a low dose of sulfonylurea. Diabetes Care 1999;22:867-8.
3. Moller AM, Dalgaard LT, Pociot F, Nerup J et al. Mutations in the hepatocyte nuclear factor-1 alpha gene in Caucasian families originally classified as having Type 1 diabetes. Diabetologia 1998;41:1528-31.
4. Frayling TM, Bulman MP, Ellard S, Appleton M et al. Mutations in the hepatocyte nuclear factor-1 alpha gene are a common cause of maturity-onset diabetes of the young in the UK. Diabetes 1997;46: 720-5.
5. Pearson ER, Starkey BJ, Powell RJ, Gribble FM et al. Genetic cause of hyperglycaemia determines response to treatment in diabetes. Lancet 2003;362:1275-81.
6. Owen KR, Hattersley AT. Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization. Review. Best Pract Res Clin Endocrinol Metab 2001;15:309-23.
7. Lambert AP, Ellard S, Allen LI, Gallen IW et al. Identifying hepatic nuclear factor 1 alpha mutations in children and young adults with a clinical diagnosis of type 1 diabetes. Diabetes Care 2003;26:333-7.
8. Shepherd M, Pearson ER, Houghton J, Salt G et al. No deterioration in glycemic control in HNF-1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas. Diabetes Care 2003;26:3191-2.
9. Shepherd M, Hattersley AT, Sparkes AC. Predictive genetic testing in diabetes: a case study of multiple perspectives. Qual Health Res 2000; 10:242-59.
10. Haugbolle LS, Devantier K, Frydenlund B. A user perspective on type 1 diabetes: sense of illness, search for freedom and the role of the pharmacy. Patient Educ Couns 2002;47:361-8.
11. Kralik D, Brown M, Koch T. Women's experiences of 'being diagnosed' with a long-term illness. J Adv Nurs 2001;33:594-602.
12. Shepherd M. 'I'm amazed I've been able to come off injections': patients' perceptions of genetic testing in diabetes. Pract Diab Int 2003;20:338-42.
13. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-8.